Department of Pathology,
Institute of Cell Engineering,
Institute for Cell Engineering,
School of Medicine,
Department of Pathology, Institute of Cell Engineering,
Institute for Cell Engineering, School of Medicine,
Department of Pathology, School of Medicine
Jonathan P. Schneck has not added Biography.
If you are Jonathan P. Schneck and would like to personalize this page please email our Author Liaison for assistance.
ImmunoMap: A Bioinformatics Tool for T-cell Repertoire Analysis.
Cancer immunology research 02, 2018 | Pubmed ID: 29263161
Differential effects of B cell receptor and B cell receptor-FcgammaRIIB1 engagement on docking of Csk to GTPase-activating protein (GAP)-associated p62.
The Journal of experimental medicine Jul, 1997 | Pubmed ID: 9221755
Analysis of the expression of peptide-major histocompatibility complexes using high affinity soluble divalent T cell receptors.
The Journal of experimental medicine Oct, 1997 | Pubmed ID: 9334373
Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients.
Proceedings of the National Academy of Sciences of the United States of America Jun, 1998 | Pubmed ID: 9636190
Lack of coreceptor allows survival of chronically stimulated double-negative alpha/beta T cells: implications for autoimmunity.
The Journal of experimental medicine May, 2001 | Pubmed ID: 11369783
Development and use of multimeric major histocompatibility complex molecules.
Clinical and diagnostic laboratory immunology Mar, 2002 | Pubmed ID: 11874855
T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens.
Nature immunology Jul, 2002 | Pubmed ID: 12055626
Probing T cell membrane organization using dimeric MHC-Ig complexes.
Journal of immunological methods Oct, 2002 | Pubmed ID: 12213346
Peptide-beta2-microglobulin-MHC fusion molecules bind antigen-specific T cells and can be used for multivalent MHC-Ig complexes.
Journal of immunological methods Dec, 2002 | Pubmed ID: 12445736
Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig-coated artificial antigen-presenting cells.
Nature medicine May, 2003 | Pubmed ID: 12704385
B220+ double-negative T cells suppress polyclonal T cell activation by a Fas-independent mechanism that involves inhibition of IL-2 production.
Journal of immunology (Baltimore, Md. : 1950) Sep, 2003 | Pubmed ID: 12928389
HLA-Ig-based artificial antigen-presenting cells: setting the terms of engagement.
Clinical immunology (Orlando, Fla.) Mar, 2004 | Pubmed ID: 15047202
Quality and quantity: new strategies to improve immunotherapy of cancer.
Trends in molecular medicine May, 2004 | Pubmed ID: 15121045
Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.
Clinical cancer research : an official journal of the American Association for Cancer Research Oct, 2004 | Pubmed ID: 15501971
Technological advances in adoptive immunotherapy.
Drugs of today (Barcelona, Spain : 1998) Jan, 2005 | Pubmed ID: 15753966
Artificial antigen-presenting cells: artificial solutions for real diseases.
Trends in molecular medicine Sep, 2005 | Pubmed ID: 16103011
Antigen/MHC class II/Ig dimers for study of uveitogenic T cells: IRBP p161-180 presented by both IA and IE molecules.
Investigative ophthalmology & visual science Oct, 2005 | Pubmed ID: 16186361
Evaluation of topoisomerase-1-specific CD8+ T-cell response in systemic sclerosis.
Annals of the New York Academy of Sciences Dec, 2005 | Pubmed ID: 16461796
Gld mutation of Fas ligand increases the frequency and up-regulates cell survival genes in CD25+CD4+ TR cells.
International immunology Aug, 2006 | Pubmed ID: 16769751
Detection of antigen-specific T cells on p/MHC microarrays.
Journal of molecular recognition : JMR Jan-Feb, 2007 | Pubmed ID: 17094178
A nanoscopic multivalent antigen-presenting carrier for sensitive detection and drug delivery to T cells.
Nanomedicine : nanotechnology, biology, and medicine Mar, 2007 | Pubmed ID: 17379171
Protection from autoimmune diabetes and T-cell lymphoproliferation induced by FasL mutation are differentially regulated and can be uncoupled pharmacologically.
The American journal of pathology Jul, 2007 | Pubmed ID: 17591957
Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells.
Blood Apr, 2008 | Pubmed ID: 18096763
In vivo functional efficacy of tumor-specific T cells expanded using HLA-Ig based artificial antigen presenting cells (aAPC).
Cancer immunology, immunotherapy : CII Feb, 2009 | Pubmed ID: 18563409
Lectin microarrays identify cell-specific and functionally significant cell surface glycan markers.
Glycobiology Oct, 2008 | Pubmed ID: 18625848
Fas-mediated apoptosis regulates the composition of peripheral alphabeta T cell repertoire by constitutively purging out double negative T cells.
PloS one , 2008 | Pubmed ID: 18941614
Ex vivo induction and expansion of natural killer T cells by CD1d1-Ig coated artificial antigen presenting cells.
Journal of immunological methods Jul, 2009 | Pubmed ID: 19446558
Development of an artificial-antigen-presenting-cell-based assay for the detection of low-frequency virus-specific CD8(+) T cells in whole blood, with application for measles virus.
Clinical and vaccine immunology : CVI Jul, 2009 | Pubmed ID: 19494085
Streptococcus pneumoniae serotype 1 capsular polysaccharide induces CD8CD28 regulatory T lymphocytes by TCR crosslinking.
PLoS pathogens Sep, 2009 | Pubmed ID: 19779562
In vivo administration of artificial antigen-presenting cells activates low-avidity T cells for treatment of cancer.
Cancer research Dec, 2009 | Pubmed ID: 19934317
Overview of a HLA-Ig based "Lego-like system" for T cell monitoring, modulation and expansion.
Immunologic research Jul, 2010 | Pubmed ID: 20087680
Dynamic regulation of functionally distinct virus-specific T cells.
Proceedings of the National Academy of Sciences of the United States of America Feb, 2010 | Pubmed ID: 20133680
Killer artificial antigen-presenting cells: the synthetic embodiment of a 'guided missile'.
Immunotherapy Jul, 2010 | Pubmed ID: 20636007
High-throughput lectin microarray-based analysis of live cell surface glycosylation.
Current protocols in protein science / editorial board, John E. Coligan ... [et al.] Feb, 2011 | Pubmed ID: 21400689
Inhibition of Fas ligand in NOD mice unmasks a protective role for IL-10 against insulitis development.
The American journal of pathology Aug, 2011 | Pubmed ID: 21718680
Decline of influenza-specific CD8+ T cell repertoire in healthy geriatric donors.
Immunity & ageing : I & A , 2011 | Pubmed ID: 21846352
Quantum dot fluorescence characterizes the nanoscale organization of T cell receptors for antigen.
Biophysical journal Dec, 2011 | Pubmed ID: 22261075
Molecular identification of GD3 as a suppressor of the innate immune response in ovarian cancer.
Cancer research Aug, 2012 | Pubmed ID: 22649190
T-cell memory responses elicited by yellow fever vaccine are targeted to overlapping epitopes containing multiple HLA-I and -II binding motifs.
PLoS neglected tropical diseases , 2013 | Pubmed ID: 23383350
Nanoscale artificial antigen presenting cells for T cell immunotherapy.
Nanomedicine : nanotechnology, biology, and medicine Jan, 2014 | Pubmed ID: 23891987
Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells.
Biomaterials Jan, 2014 | Pubmed ID: 24099710
Sprouty-2 regulates HIV-specific T cell polyfunctionality.
The Journal of clinical investigation Jan, 2014 | Pubmed ID: 24292711
Magnetic field-induced T cell receptor clustering by nanoparticles enhances T cell activation and stimulates antitumor activity.
ACS nano Mar, 2014 | Pubmed ID: 24564881
Linking form to function: Biophysical aspects of artificial antigen presenting cell design.
Biochimica et biophysica acta Apr, 2015 | Pubmed ID: 25200637
Cytotoxic polyfunctionality maturation of cytomegalovirus-pp65-specific CD4 + and CD8 + T-cell responses in older adults positively correlates with response size.
Scientific reports Jan, 2016 | Pubmed ID: 26778409
Dual Targeting Nanoparticle Stimulates the Immune System To Inhibit Tumor Growth.
ACS nano 06, 2017 | Pubmed ID: 28589725
Biologically Inspired Design of Nanoparticle Artificial Antigen-Presenting Cells for Immunomodulation.
Nano letters 11, 2017 | Pubmed ID: 28994285
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab.
Cell Nov, 2017 | Pubmed ID: 29033130
Engineering Platforms for T Cell Modulation.
International review of cell and molecular biology , 2018 | Pubmed ID: 30262034
Efficient magnetic enrichment of antigen-specific T cells by engineering particle properties.
Biomaterials Dec, 2018 | Pubmed ID: 30312851
SOBRE A JoVE
Copyright © 2024 MyJoVE Corporation. Todos os direitos reservados